Response to Comments: Parenteral Nutrition - DL38953

This document is a response to comments received during the 45-day comment period (Feb 9–Mar 25, 2023) for the proposed Parenteral Nutrition LCD (DL38953) and notes that one commenter provided feedback. It explains that DME MACs may consolidate, redact, or withhold comments (e.g., private/proprietary content or duplicates) and does not itself define coverage criteria; refer to LCD DL38953 for clinical coverage determinations.

"The DME MACs received comments from one commenter during the 45-day open comment period for the proposed Parenteral Nutrition LCD (DL38953)."

Sign up to see full coverage criteria, indications, and limitations.